Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0733 | 0.0759 |
Schistosoma mansoni | hypothetical protein | 0.0144 | 0.4719 | 0.489 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.021 | 0.7183 | 0.7443 |
Loa Loa (eye worm) | hypothetical protein | 0.021 | 0.7183 | 0.7443 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.186 | 0.1928 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0066 | 0.186 | 0.1928 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.965 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0733 | 0.0759 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.8713 | 0.9029 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.4719 | 0.489 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.021 | 0.7183 | 0.7443 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0277 | 0.965 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0277 | 0.965 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0239 | 0.8255 | 0.8554 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0025 | 0.0316 | 0.0328 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0055 | 0.1447 | 0.5 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.8713 | 0.9029 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0055 | 0.1447 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.965 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0055 | 0.1447 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0055 | 0.1447 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0055 | 0.1447 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0277 | 0.965 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0066 | 0.186 | 0.1928 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0055 | 0.1447 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0316 | 0.0328 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0036 | 0.0733 | 0.0759 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.186 | 0.1928 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0066 | 0.186 | 0.1928 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 1 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0277 | 0.965 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0733 | 0.0759 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0025 | 0.0316 | 0.0328 |
Echinococcus multilocularis | GPCR, family 2 | 0.0066 | 0.186 | 0.1928 |
Brugia malayi | hypothetical protein | 0.0036 | 0.0721 | 0.0747 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.021 | 0.7183 | 0.7443 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0733 | 0.0759 |
Loa Loa (eye worm) | RNA binding protein | 0.0277 | 0.965 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0733 | 0.0759 |
Brugia malayi | MH2 domain containing protein | 0.0239 | 0.8255 | 0.8554 |
Leishmania major | hypothetical protein, conserved | 0.0055 | 0.1447 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0733 | 0.0759 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0055 | 0.1447 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0144 | 0.4719 | 0.489 |
Echinococcus granulosus | tar DNA binding protein | 0.0277 | 0.965 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0066 | 0.186 | 0.1928 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0066 | 0.186 | 0.1928 |
Brugia malayi | RNA binding protein | 0.0277 | 0.965 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0277 | 0.965 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0066 | 0.186 | 0.1928 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0733 | 0.0759 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.965 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.186 | 0.1928 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.186 | 0.1928 |
Brugia malayi | hypothetical protein | 0.0055 | 0.1447 | 0.15 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0684 | 0.0708 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.1447 | 0.15 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.186 | 0.1928 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.965 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0066 | 0.186 | 0.1928 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0239 | 0.8255 | 0.8554 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0733 | 0.0759 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0066 | 0.186 | 0.1928 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.965 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.8184 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.